Non-small cell lung carcinoma cell motility, Rac activation and metastatic dissemination are mediated by protein kinase C epsilon

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Caino, M Cecilia ^a   Lopez Haber, Cynthia ^a   Kissil, Joseph L ^b   Kazanietz, Marcelo G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; CLUSTERIN; COLLAGENASE 3; EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; NEUTROPHIL COLLAGENASE; PROTEIN KINASE C EPSILON; PROTEINASE; PROTEINASE INHIBITOR; RAC PROTEIN; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; GUANOSINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DISSEMINATED CANCER; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN SECRETION; ANIMAL; CARCINOMA; CELL MOTION; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANOSINE TRIPHOSPHATE; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROTEIN KINASE C-EPSILON; RAC GTP-BINDING PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84857578369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031714     Document Type: Article

References (66)

1. Huber RM, Stratakis DF, (2004) Molecular oncology-perspectives in lung cancer. Lung Cancer 45 (Suppl 2): S209-213.
2. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
3. Sekido Y, Fong KM, Minna JD, (2003) Molecular genetics of lung cancer. Annu Rev Med 54: 73-87.
4. Griner EM, Kazanietz MG, (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281.
5. Yang C, Kazanietz MG, (2003) Divergence and complexities in DAG signaling: looking beyond PKC. Trends Pharmacol Sci 24: 602-608.
6. Griner EM, Caino MC, Soledad Sosa M, Colon-Gonzalez F, Chalmers MJ, et al. (2010) A novel cross-talk in diacylglycerol signaling: the Rac-GAP beta2-chimaerin is negatively regulated by protein kinase Cdelta-mediated phosphorylation. J Biol Chem 285: 16931-16941.
7. Caino MC, Meshki J, Kazanietz MG, (2009) Hallmarks for senescence in carcinogenesis: novel signaling players. Apoptosis 14: 392-408.
8. Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK, et al. (2005) Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 280: 33926-33934.
9. Oliva JL, Caino MC, Senderowicz AM, Kazanietz MG, (2008) S-Phase-specific Activation of PKC{alpha} Induces Senescence in Non-small Cell Lung Cancer Cells. J Biol Chem 283: 5466-5476.
10. Bae KM, Wang H, Jiang G, Chen MG, Lu L, et al. (2007) Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res 67: 6053-6063.
11. Basu A, Sivaprasad U, (2007) Protein kinase Cepsilon makes the life and death decision. Cell Signal 19: 1633-1642.
12. Ding L, Wang H, Lang W, Xiao L, (2002) Protein Kinase C-epsilon Promotes Survival of Lung Cancer Cells by Suppressing Apoptosis through Dysregulation of the Mitochondrial Caspase Pathway. J Biol Chem 277: 35305-35313.
13. Felber M, Sonnemann J, Beck JF, (2007) Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells. Pathol Oncol Res 13: 295-301.
14. Gorin MA, Pan Q, (2009) Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Mol Cancer 8: 9.
15. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, et al. (1993) Overexpression of protein kinase C-delta and-epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268: 6090-6096.
16. Perletti GP, Folini M, Lin HC, Mischak H, Piccinini F, et al. (1996) Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells. Oncogene 12: 847-854.
17. Grossoni VC, Falbo KB, Mauro LV, Krasnapolski MA, Kazanietz MG, et al. (2007) Protein kinase C delta inhibits the production of proteolytic enzymes in murine mammary cells. Clin Exp Metastasis 24: 513-520.
18. Grossoni VC, Todaro LB, Kazanietz MG, de Kier Joffe ED, Urtreger AJ, (2009) Opposite effects of protein kinase C beta1 (PKCbeta1) and PKCepsilon in the metastatic potential of a breast cancer murine model. Breast Cancer Res Treat 118: 469-480.
19. Pan Q, Bao LW, Teknos TN, Merajver SD, (2006) Targeted Disruption of Protein Kinase C{varepsilon} Reduces Cell Invasion and Motility through Inactivation of RhoA and RhoC GTPases in Head and Neck Squamous Cell Carcinoma. Cancer Res 66: 9379-9384.
20. Tachado SD, Mayhew MW, Wescott GG, Foreman TL, Goodwin CD, et al. (2002) Regulation of tumor invasion and metastasis in protein kinase C epsilon-transformed NIH3T3 fibroblasts. J Cell Biochem 85: 785-797.
21. Tuomi S, Mai A, Nevo J, Laine JO, Vilkki V, et al. (2009) PKCepsilon regulation of an alpha5 integrin-ZO-1 complex controls lamellae formation in migrating cancer cells. Sci Signal 2: ra32.
22. Gujdar A, Sipeki S, Bander E, Buday L, Farago A, (2003) Phorbol ester-induced migration of HepG2 cells is accompanied by intensive stress fibre formation, enhanced integrin expression and transient down-regulation of p21-activated kinase 1. Cell Signal 15: 307-318.
23. Xiao H, Eves R, Yeh C, Kan W, Xu F, et al. (2009) Phorbol ester-induced podosomes in normal human bronchial epithelial cells. J Cell Physiol 218: 366-375.
24. Schmitz AA, Govek EE, Bottner B, Van Aelst L, (2000) Rho GTPases: signaling, migration, and invasion. Exp Cell Res 261: 1-12.
25. Urtreger AJ, Grossoni VC, Falbo KB, Kazanietz MG, Bal de Kier Joffe ED, (2005) Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells. Mol Carcinog 42: 29-39.
26. Sosa MS, Lopez-Haber C, Yang C, Wang H, Lemmon MA, et al. (2010) Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell 40: 877-892.
27. Yang C, Liu Y, Lemmon MA, Kazanietz MG, (2006) Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4. Mol Cell Biol 26: 831-842.
28. Caino MC, von Burstin VA, Lopez-Haber C, Kazanietz MG, (2011) Differential Regulation of Gene Expression by Protein Kinase C Isozymes as Determined by Genome-wide Expression Analysis. J Biol Chem 286: 11254-11264.
29. Jiang Y, Cui L, Yie TA, Rom WN, Cheng H, et al. (2001) Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta. Oncogene 20: 2254-2263.
30. Ramesh R, Saeki T, Templeton NS, Ji L, Stephens LC, et al. (2001) Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther 3: 337-350.
31. Santos AM, Jung J, Aziz N, Kissil JL, Pure E, (2009) Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest 119: 3613-3625.
32. Barry OP, Kazanietz MG, (2001) Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Des 7: 1725-1744.
33. Etienne-Manneville S, Hall A, (2002) Rho GTPases in cell biology. Nature 420: 629-635.
34. Hall A, (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509-514.
35. Caloca MJ, Wang H, Kazanietz MG, (2003) Characterization of the Rac-GAP (Rac-GTPase-activating protein) activity of beta2-chimaerin, a 'non-protein kinase C' phorbol ester receptor. Biochem J 375: 313-321.
36. Mellstrom K, Heldin CH, Westermark B, (1988) Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor. Exp Cell Res 177: 347-359.
37. Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM, (1999) c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev 13: 2400-2411.
38. Suzuki T, Seth A, Rao R, (2008) Role of phospholipase Cgamma-induced activation of protein kinase Cepsilon (PKCepsilon) and PKCbetaI in epidermal growth factor-mediated protection of tight junctions from acetaldehyde in Caco-2 cell monolayers. J Biol Chem 283: 3574-3583.
39. Toker A, (1998) Signaling through protein kinase C. Front Biosci 3: D1134-1147.
40. Budas GR, Koyanagi T, Churchill EN, Mochly-Rosen D, (2007) Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic. Biochem Soc Trans 35: 1021-1026.
41. Gray MO, Karliner JS, Mochly-Rosen D, (1997) A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 272: 30945-30951.
42. Inagaki K, Begley R, Ikeno F, Mochly-Rosen D, (2005) Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 111: 44-50.
43. Koyanagi T, Noguchi K, Ootani A, Inagaki K, Robbins RC, et al. (2007) Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model. J Mol Cell Cardiol 43: 517-522.
44. Stetler-Stevenson WG, Aznavoorian S, Liotta LA, (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573.
45. Price LS, Collard JG, (2001) Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin Cancer Biol 11: 167-173.
46. Dallol A, Agathanggelou A, Tommasi S, Pfeifer GP, Maher ER, et al. (2005) Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res 65: 7653-7659.
47. Brantley-Sieders DM, Zhuang G, Vaught D, Freeman T, Hwang Y, et al. (2009) Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo. Mol Cancer Res 7: 615-623.
48. Justilien V, Fields AP, (2009) Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene 28: 3597-3607.
49. Lazer G, Idelchuk Y, Schapira V, Pikarsky E, Katzav S, (2009) The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis. J Pathol 219: 25-34.
50. Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, et al. (2005) Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res 65: 8366-8371.
51. Jansen AP, Verwiebe EG, Dreckschmidt NE, Wheeler DL, Oberley TD, et al. (2001) Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res 61: 808-812.
52. Gorshkova I, He D, Berdyshev E, Usatuyk P, Burns M, et al. (2008) Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1. J Biol Chem 283: 11794-11806.
53. Binker MG, Binker-Cosen AA, Richards D, Gaisano HY, de Cosen RH, et al. (2010) Hypoxia-reoxygenation increase invasiveness of PANC-1 cells through Rac1/MMP-2. Biochem Biophys Res Commun 393: 371-376.
54. Ferri N, Colombo G, Ferrandi C, Raines EW, Levkau B, et al. (2007) Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol 27: 1043-1049.
55. Santibanez JF, Kocic J, Fabra A, Cano A, Quintanilla M, (2010) Rac1 modulates TGF-beta1-mediated epithelial cell plasticity and MMP9 production in transformed keratinocytes. FEBS Lett 584: 2305-2310.
56. Frederick LA, Matthews JA, Jamieson L, Justilien V, Thompson EA, et al. (2008) Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene 27: 4841-4853.
57. Rossman KL, Der CJ, Sondek J, (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180.
58. Ishida M, Itsukaichi T, Kobayashi D, Kikuchi H, (2010) Alteration of the PKC theta-Vav1 complex and phosphorylation of Vav1 in TCDD-induced apoptosis in the lymphoblastic T cell line, L-MAT. Toxicology 275: 72-78.
59. Birkenfeld J, Nalbant P, Bohl BP, Pertz O, Hahn KM, et al. (2007) GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. Dev Cell 12: 699-712.
60. Chahdi A, Sorokin A, (2008) Protein kinase A-dependent phosphorylation modulates beta1Pix guanine nucleotide exchange factor activity through 14-3-3beta binding. Mol Cell Biol 28: 1679-1687.
61. Takefuji M, Mori K, Morita Y, Arimura N, Nishimura T, et al. (2007) Rho-kinase modulates the function of STEF, a Rac GEF, through its phosphorylation. Biochem Biophys Res Commun 355: 788-794.
62. Chang YC, Lee HH, Chen YJ, Bokoch GM, Chang ZF, (2006) Contribution of guanine exchange factor H1 in phorbol ester-induced apoptosis. Cell Death Differ 13: 2023-2032.
63. Mehta D, Rahman A, Malik AB, (2001) Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem 276: 22614-22620.
64. Scholz RP, Regner J, Theil A, Erlmann P, Holeiter G, et al. (2009) DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling. J Cell Sci 122: 92-102.
65. Goekjian PG, Jirousek MR, (2001) Protein kinase C inhibitors as novel anticancer drugs. Expert Opin Investig Drugs 10: 2117-2140.
66. Serova M, Ghoul A, Benhadji KA, Cvitkovic E, Faivre S, et al. (2006) Preclinical and clinical development of novel agents that target the protein kinase C family. Semin Oncol 33: 466-478.